Skip to main content

Arizona Centers Team on Heart, Vascular Studies

NEW YORK (GenomeWeb News) – Arizona Heart Institute and Arizona Research Center will partner on cardiovascular research that will include genomics, epigenetics, and large, multi-center drug and medical device trials, AHI said today.

The collaboration, focused on heart and vascular diseases, will give AZRC access to patients that may qualify for pharmaceutical and device research studies, and will enable AHI to pursue epigenetic and genomic studies in efforts to develop early-stage diagnostics that could allow for interventions before symptoms present.

AZRC represents a network of doctors and hospitals that support its research, and AHI includes the Arizona Heart Hospital and the Arizona Heart Institute Translational Research Center.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.